Clinical Trial Update: Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases

View source ↗

Summary

The update describes a study examining genomic and epigenomic biomarkers of immune system deregulation in Crohn's disease; the current status of the trial is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Crohn Disease | Status: UNKNOWN